Post

New research · Ophthalmology
In vivo (Athens, Greece) · 1d
Case reportIn vivo (Athens, Greece) · 2026

Management of a Complex Orbital Post-transplantation Lymphoproliferative Disorder: A Case Report and Literature Review.

Tessho Maruyama, Yohei Hokama, Kazutaka Kishaba … Tadashi Hamasaki
Read paper
OphthalmologyCase report

Localized orbital lymphoproliferative disorder remained in remission after immunosuppression reduction alone.

Management of a Complex Orbital Post-transplantation Lymphoproliferative Disorder: A Case Report and Literature Review.

Tessho Maruyama … Tadashi Hamasaki
In vivo (Athens, Greece) · 2026
Background

Post-transplantation lymphoproliferative disorder (post-transplantation lymphoproliferative disorder) is an uncommon but serious complication of organ transplantation.

13
Results
13
months
immunosuppression alone kept the eye lesion controlled, no relapse, over a year
More results

Management often requires multiple treatment modalities and reduction in immunosuppressant treatment (reduction in immunosuppressant treatment).

Orbital involvement is rare, and optimal diagnostic and therapeutic approaches remain uncertain.

More results

CASE REPORT: Here, we report a case of localized orbital post-transplantation lymphoproliferative disorder that was successfully treated with reduction in immunosuppressant treatment alone.

A 62-year-old man, who had undergone kidney transplantation 18 years prior, presented with left eye pain and proptosis.

“
Conclusion

This case suggests the potential role of a conservative, individualized, stepwise approach in selected patients with localized orbital post-transplantation lymphoproliferative disorder, and may inform management strategies for other localized forms of post-transplantation lymphoproliferative disorder.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment